[Utilization of routine data from different statutory health insurance funds: a practical report of experience from the TIM-HF2 study about data acquisition, validation, and processing].

Autor: Winkler H; Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité - Universitätsmedizin Berlin, Luisenstr. 57, 10117, Berlin, Deutschland. hanna.winkler@charite.de., Koehler F; CharitéCentrum 11 (CC 11) für Herz‑, Kreislauf- und Gefäßmedizin, Medizinische Klinik mit Schwerpunkt Kardiologie und Angiologie, Arbeitsbereich kardiovaskuläre Telemedizin, Charité - Universitätsmedizin Berlin, Berlin, Deutschland., Reinhold T; Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité - Universitätsmedizin Berlin, Luisenstr. 57, 10117, Berlin, Deutschland., Willich SN; Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité - Universitätsmedizin Berlin, Luisenstr. 57, 10117, Berlin, Deutschland., Prescher S; CharitéCentrum 11 (CC 11) für Herz‑, Kreislauf- und Gefäßmedizin, Medizinische Klinik mit Schwerpunkt Kardiologie und Angiologie, Arbeitsbereich kardiovaskuläre Telemedizin, Charité - Universitätsmedizin Berlin, Berlin, Deutschland.
Jazyk: němčina
Zdroj: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz [Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz] 2023 Sep; Vol. 66 (9), pp. 1000-1007. Date of Electronic Publication: 2023 Jun 30.
DOI: 10.1007/s00103-023-03735-y
Abstrakt: Background: The randomized controlled clinical trial "TIM-HF2" investigated the benefit of telemonitoring in chronic heart failure. The health economic evaluation of this intervention was based on routine data from statutory health insurance (SHI) funds. Since participants were recruited independently of their SHI affiliation, there was a large number of potential data-providing SHI funds. This resulted in both organizational and methodological challenges, from participation of the data providers to data preparation.
Method: The procedures are described from study planning and data acquisition to data review and processing in the TIM-HF2 trial. Based on the identification of potential problems for data completeness and data quality, possible solutions have been derived.
Results: In total, participants were insured with 49 different SHI funds, which provided routine data for a total of 1450 participants. About half of all initial data deliveries were correct. The most common problems in data preparation occurred in the machine readability of the data. Success factors for a high level of data completeness were close communication with the SHI funds and a high level of time and personnel commitment to intensive data checking and preparation.
Discussion: Based on the experience of the TIM-HF2 trial, a high heterogeneity has been detected in data management and transmission of routine data. Universally applicable data descriptions are desired to improve data access, quality, and usability for research purposes.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz: